Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1951 2
1952 2
1956 1
1957 1
1958 1
1960 2
1961 5
1962 4
1963 4
1964 7
1965 16
1966 8
1967 9
1968 6
1969 3
1970 6
1971 6
1972 2
1973 8
1974 8
1975 10
1976 4
1977 4
1978 3
1979 2
1980 1
1981 3
1982 2
1983 6
1984 5
1985 14
1986 8
1987 8
1988 9
1989 19
1990 15
1991 31
1992 26
1993 17
1994 11
1995 6
1996 13
1997 9
1998 23
1999 12
2000 17
2001 24
2002 19
2003 32
2004 28
2005 36
2006 21
2007 39
2008 42
2009 29
2010 34
2011 33
2012 38
2013 58
2014 50
2015 59
2016 49
2017 56
2018 60
2019 84
2020 83
2021 106
2022 79
2023 78
2024 64
2025 62

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,500 results

Results by year

Filters applied: . Clear all
Page 1
Hepaticojejunostomy for bile duct injury: state of the art.
Marichez A, Adam JP, Laurent C, Chiche L. Marichez A, et al. Among authors: laurent c. Langenbecks Arch Surg. 2023 Feb 27;408(1):107. doi: 10.1007/s00423-023-02818-3. Langenbecks Arch Surg. 2023. PMID: 36843190 Review.
THBS1+ myeloid cells expand in SLD hepatocellular carcinoma and contribute to immunosuppression and unfavorable prognosis through TREM1.
Giraud J, Chalopin D, Ramel E, Boyer T, Zouine A, Derieppe MA, Larmonier N, Adotevi O, Le Bail B, Blanc JF, Laurent C, Chiche L, Derive M, Nikolski M, Saleh M. Giraud J, et al. Among authors: laurent c. Cell Rep. 2024 Feb 27;43(2):113773. doi: 10.1016/j.celrep.2024.113773. Epub 2024 Feb 12. Cell Rep. 2024. PMID: 38350444 Free article.
Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Houot R, Bachy E, Cartron G, Gros FX, Morschhauser F, Oberic L, Gastinne T, Feugier P, Duléry R, Thieblemont C, Joris M, Jardin F, Choquet S, Casasnovas O, Brisou G, Cheminant M, Bay JO, Gutierrez FL, Menard C, Tarte K, Delfau MH, Portugues C, Itti E, Palard-Novello X, Blanc-Durand P, Al Tabaa Y, Bailly C, Laurent C, Lemonnier F. Houot R, et al. Among authors: laurent c. Nat Med. 2023 Oct;29(10):2593-2601. doi: 10.1038/s41591-023-02572-5. Epub 2023 Sep 14. Nat Med. 2023. PMID: 37710005 Free PMC article. Clinical Trial.
Carcinogenicity.
Maurici D, Aardema M, Corvi R, Kleber M, Krul C, Laurent C, Loprieno N, Pasanen M, Pfuhler S, Phillips B, Prentice D, Sabbioni E, Sanner T, Vanparys P. Maurici D, et al. Among authors: laurent c. Altern Lab Anim. 2005 Jul;33 Suppl 1:177-82. doi: 10.1177/026119290503301s16. Altern Lab Anim. 2005. PMID: 16194148 No abstract available.
Blockage of ATGL-mediated breakdown of lipid droplets in microglia alleviates neuroinflammatory and behavioural responses to lipopolysaccharides.
Robb JL, Boisjoly F, Machuca-Parra AI, Coursan A, Manceau R, Majeur D, Rodaros D, Bouyakdan K, Greffard K, Bilodeau JF, Forest A, Daneault C, Ruiz M, Laurent C, Arbour N, Layé S, Fioramonti X, Madore C, Fulton S, Alquier T; Representative of consortium. Robb JL, et al. Among authors: laurent c. Brain Behav Immun. 2025 Jan;123:315-333. doi: 10.1016/j.bbi.2024.09.027. Epub 2024 Sep 24. Brain Behav Immun. 2025. PMID: 39326768 Free article.
Neurologic manifestations of giant cell arteritis.
Soulages A, Sibon I, Vallat JM, Ellie E, Bourdain F, Duval F, Carla L, Martin-Négrier ML, Solé G, Laurent C, Monnier A, Le Masson G, Mathis S. Soulages A, et al. Among authors: laurent c. J Neurol. 2022 Jul;269(7):3430-3442. doi: 10.1007/s00415-022-10991-6. Epub 2022 Feb 6. J Neurol. 2022. PMID: 35124749 Review.
Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine.
Faria C, Gava F, Gravelle P, Valero JG, Dobaño-López C, Van Acker N, Quelen C, Jalowicki G, Morin R, Rossi C, Lagarde JM, Fournié JJ, Ysebaert L, Laurent C, Pérez-Galán P, Bezombes C. Faria C, et al. Among authors: laurent c. J Immunother Cancer. 2023 Oct;11(10):e007156. doi: 10.1136/jitc-2023-007156. J Immunother Cancer. 2023. PMID: 37899130 Free PMC article.
Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA study.
Cartron G, Houot R, Al Tabaa Y, Le Bras F, Ysebaert L, Choquet S, Jardin F, Bay JO, Gros FX, Morschhauser F, Casasnovas O, Gastinne T, Thieblemont C, Joris M, Ricard L, Regny C, Drieu La Rochelle L, Feugier P, Marcais A, Griolet S, Tarte K, Laurent C, Sesques P. Cartron G, et al. Among authors: laurent c. Nat Cancer. 2025 Jul;6(7):1173-1183. doi: 10.1038/s43018-025-00941-2. Epub 2025 Apr 3. Nat Cancer. 2025. PMID: 40181090 Clinical Trial.
1,500 results